How It Works
The COX and LOX pathways are among the body's central assembly lines for making inflammatory messengers. Both start from arachidonic acid, a fatty acid released from cell membranes when a cell is stressed, injured, or activated by the immune system. The cyclooxygenase route turns that fatty acid into prostaglandins and thromboxanes, molecules involved in pain, fever, blood-vessel tone, and platelet stickiness. The lipoxygenase route instead produces leukotrienes and related lipids that recruit immune cells and are closely studied in airway and allergic responses. In everyday terms, these two pathways act like branching production lines, and understanding which branch is most active helps explain the character of an inflammatory response.
The Science & Mechanism
Both pathways begin when phospholipase A2 liberates arachidonic acid, a 20-carbon omega-6 fatty acid, from membrane phospholipids. In the cyclooxygenase branch, COX-1 and COX-2 convert arachidonic acid into the unstable intermediate prostaglandin H2, which downstream synthases then shape into specific prostaglandins (such as PGE2 and PGI2) and thromboxane A2. COX-1 is often described as constitutive, supporting housekeeping roles like gastric mucosal protection and platelet aggregation, while COX-2 is largely inducible and upregulated at sites of inflammation, though research notes this distinction is a simplification with overlap between the two. In the lipoxygenase branch, 5-LOX, working with the accessory protein FLAP, converts arachidonic acid toward leukotriene A4, which becomes either LTB4, a strong chemoattractant for neutrophils, or the cysteinyl leukotrienes (LTC4, LTD4, LTE4) associated with bronchoconstriction and vascular permeability. Other lipoxygenases (12-LOX, 15-LOX) generate additional lipid mediators, including precursors of pro-resolving lipoxins. These eicosanoids act through G-protein-coupled receptors such as the EP, DP, TP, and CysLT families. Research also describes substrate competition, in which omega-3 fatty acids shift enzyme output toward less inflammatory mediators.
Potential Benefits
- May support understanding of how a balanced inflammatory response is generated and controlled
- Studied for its role in producing prostaglandins that shape pain, fever, and vascular signaling
- Studied for its role in producing leukotrienes involved in immune-cell recruitment and airway responses
- Research explores how nutrients and botanicals are associated with modulating COX-2 and 5-LOX activity
- May support a framework for understanding the omega-3 versus omega-6 fatty-acid balance
- Studied for its role in the shift from active inflammation toward resolution via lipoxin-type mediators
Who It May Be Best Suited For
- Adults wanting to understand the biology behind their inflammatory tone
- Those exploring how diet and omega-3 balance may influence inflammatory signaling
- Patients interested in the mechanisms behind joint comfort and everyday mobility
- Anyone building a foundational, labs-guided optimization and longevity plan
Important Considerations
This information is educational only and is intended to explain a biological pathway, not to diagnose, treat, cure, or prevent any disease. How this science informs your personalized plan, including any nutritional or lifestyle strategies that touch these pathways, is decided one-on-one with Dr. Rob based on your labs, personal history, and goals. These statements have not been evaluated by the FDA, and individual responses vary.
